Document is current
Any future updates will be listed below
-
Authors
Roy, Anindo
Hennessie, Bradley
Hafer-Macko, Charlene
Forrester, Larry W.
Westlake, Kelly
Macko, Richard F.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04594837 at ClinicalTrials.govDocuments that mention this clinical trial
Adaptive control ankle robotics training durably improves gait biomechanics in chronic hemiparetic stroke and footdrop
https://doi.org/10.1186/s12984-025-01834-2
-
Funding
Funding for this research was provided by:
National Institutes of Health (5U44NS111076)
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 28 November 2025
First Online: 29 December 2025
Declarations
:
: Salus Institutional Review Board approved the protocol and the informed consent form (Salus 22226-1U44NS111076-01; Portable Ankle Robotics to Reverse Foot Drop After Stroke). All participants provided informed consent before participation in the study.
: Not applicable.
: The authors declare potential conflict of interest as follows: Drs. A. Roy, L. W. Forrester, and R.F. Macko are co-inventors in the UMB patents for AMBLE and its control system (US Patents 9,943,459; 11,337,622). Drs. Roy, Macko, Forrester, and Mr. Hennessie are co-founders of and hold equity in NextStep Robotics, Inc., the company that manufactures this type of technology under license to University of Maryland Baltimore.
